Accomplished Scientist to Lead BASi Global Research and Development
Complete the form below to unlock access to ALL audio articles.
BASi (Bioanalytical Systems Inc.), a leader in contract drug discovery and development services and research instrumentation, has hired Michael Zhou, Ph.D. as its new Senior Director of Research and Development.
Zhou joins BASi after working as the Director of Bioanalytical Chemistry/DMPK at Synta Pharmaceuticals Corporation in Lexington, Mass.
Zhou is a highly regarded expert on analytical/bioanalytical operations and regulatory compliance, including Good Laboratory Practice (GLP), cGMP, GCP regulations and ICH, GCLP, BMV guidelines.
He has given numerous presentations and workshops on these topics at conferences around the world. He has authored more than 50 research articles.
Zhou will guide the method development program and will be BASi's lead for the discovery bioanalytical support group.
"Michael's experience will consolidate our already strong reputation for developing the more challenging bioanalytical methods. In his R&D role, Michael will evaluate and implement new cost effective approaches to our bioanalytical process that will accelerate our growth and profitability," said President and Chief Executive Officer Anthony S. Chilton, Ph.D.
"We will increase our international exposure as Michael represents us in industry conferences, meetings and workshops."
